A Study of Cabiralzumab Given by Itself or With Nivolumab in Advanced Cancer or Cancer That Has Spread
Clinical trial NCT03158272 · COMPLETED
Trial details
- NCT number
- NCT03158272
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-25
- Primary completion
- 2019-10-23
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.